THYROID CARCINOMA
Clinical trials for THYROID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks sorafenib safety in Hard-to-Treat thyroid cancer
Disease control OngoingThis study monitors 453 patients with advanced thyroid cancer that cannot be removed by surgery and does not respond to radioactive iodine. All patients are taking the drug sorafenib (Nexavar) as part of their normal care. Researchers are tracking side effects and how long patien…
Matched conditions: THYROID CARCINOMA
Sponsor: Bayer • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
Keytruda takes on 15 advanced cancers in major trial
Disease control OngoingThis phase 2 trial tests the immunotherapy drug pembrolizumab (Keytruda) in people with 15 types of advanced solid tumors that have worsened after standard treatments. About 1,600 participants receive the drug to see if their tumors shrink or stop growing. The study also looks fo…
Matched conditions: THYROID CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC